Based on data from 2013 to 2016, an estimated 4.1 million adults in the US had past or current HCV infection.1 During the 21st century, the incidence of acute HCV infection has substantially increased among individuals aged 20 to 49 years.2-4 Hepatitis C virus infection is commonly asymptomatic and associated with no clinical signs of active disease in its early stages. Oral non–interferon-based therapeutics result in undetectable HCV levels (ie, virologic cure) for most patients treated with these well-tolerated, short-term regimens. Untreated HCV infection progresses to a chronic state in more than 50% of individuals with viremia,2 and chronic HCV infection is a leading etiology for both chronic liver disease and liver transplantation in the US. Screening and treatment for HCV infection in the US population are key to mitigating morbidity and mortality.5
Wenger HC, Cifu AS, Kim AY. Screening for Hepatitis C Virus. JAMA. 2021;326(4):348–349. doi:10.1001/jama.2020.27041
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.